1. Home
  2. IH vs RCEL Comparison

IH vs RCEL Comparison

Compare IH & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$2.59

Market Cap

142.2M

Sector

Real Estate

ML Signal

HOLD

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$3.50

Market Cap

114.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
RCEL
Founded
1996
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
142.2M
114.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
IH
RCEL
Price
$2.59
$3.50
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$11.75
AVG Volume (30 Days)
12.3K
204.3K
Earning Date
12-26-2025
11-06-2025
Dividend Yield
3.37%
N/A
EPS Growth
N/A
N/A
EPS
0.29
N/A
Revenue
$123,215,612.00
$72,401,000.00
Revenue This Year
$39.02
$13.12
Revenue Next Year
N/A
$27.56
P/E Ratio
$8.81
N/A
Revenue Growth
N/A
20.59
52 Week Low
$1.55
$3.35
52 Week High
$3.60
$14.16

Technical Indicators

Market Signals
Indicator
IH
RCEL
Relative Strength Index (RSI) 37.24 36.87
Support Level $2.66 $3.42
Resistance Level $2.89 $3.93
Average True Range (ATR) 0.16 0.21
MACD -0.03 0.00
Stochastic Oscillator 0.00 11.94

Price Performance

Historical Comparison
IH
RCEL

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: